Covered recipient · General Payments record
KELLY LENNON
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$3,444.01
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $302.11 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $80.65 | 3 |
| Medtronic, Inc. | $47.83 | 2 |
| Organon LLC | $43.22 | 2 |
| Hologic Sales and Service, LLC | $36.98 | 2 |
| ABBVIE INC. | $32.71 | 2 |
| Novo Nordisk AS | $17.57 | 1 |
| C. R. BARD, INC. & SUBSIDIARIES | $16.06 | 1 |
| Daiichi Sankyo Inc. | $15.49 | 1 |
| Channel Medsystems, Inc. | $11.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.21 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161694 | CMS |
| ABBVIE INC. | $19.50 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161696 | CMS |
| Astellas Pharma US Inc | $19.68 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139277560 | CMS |
| Astellas Pharma US Inc | $29.85 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139291400 | CMS |
| Astellas Pharma US Inc | $31.12 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139269508 | CMS |
| C. R. Bard, Inc. & Subsidiaries | $16.06 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130838726 | CMS |
| Channel Medsystems, Inc. | $11.60 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067477949 | CMS |
| Daiichi Sankyo Inc. | $15.49 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089448188 | CMS |
| Hologic Sales and Service, LLC | $18.66 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084867993 | CMS |
| Hologic Sales and Service, LLC | $18.32 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084868077 | CMS |
| Medtronic, Inc. | $19.09 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117086037 | CMS |
| Medtronic, Inc. | $28.74 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117086039 | CMS |
| Novo Nordisk Inc | $17.57 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097183748 | CMS |
| Organon Llc | $21.78 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136194486 | CMS |
| Organon Llc | $21.44 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136194488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.